May 6, 2021 | News, Regulatory
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the early detection of oral and throat cancer through their proprietary mRNA technology in combination with Viome’s next-gen AI platform. The first-of-its-kind tool...
Apr 8, 2021 | News, Regulatory
The U.S. Food and Drug Administration (FDA) has granted Donisi De Novo clearance for its contact-free multiparameter measurement system. The innovative system is backed by 26 patents and consists of a combination of artificial intelligence (AI), algorithms, and...
Oct 8, 2020 | News, Regulatory
A United Arab Emirates company, Group42 or G42, is nearing the end of phase 3 clinical trials for a Chinese COVID-19 vaccine. They are hoping to start producing in the masses next year. This potential vaccine was a product of the partnership between G42, an Abu-Dhabi...
Oct 5, 2020 | News, Regulatory
Nvidia, a chip industry giant from the U.S., announced today (10/5) that they will be building a supercomputer called Cambridge-1 which will channel artificial intelligence technologies to help researchers find solutions to urgent medical challenges such as COVID-19....
Aug 26, 2020 | News, Regulatory
RenalytixAI, an in vitro diagnostics that uses artificial intelligence, has filed a submission to the FDA to clear new kidney treatment called KidneyIntelx. KidneyIntelx is designed to optimize clinical management and patient outcomes of kidney disease research as...
